Simplex Trading’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-38,598
| Closed | -$117K | – | 10006 |
|
|
2024
Q4 | $117K | Buy |
38,598
+14,220
| +58% | +$61.9K | ﹤0.01% | 5043 |
|
|
2024
Q3 | $126K | Sell |
24,378
-33,744
| -58% | -$168K | ﹤0.01% | 4999 |
|
|
2024
Q2 | $149K | Buy |
+58,122
| New | +$198K | ﹤0.01% | 4942 |
|
|
2023
Q4 | – | Sell |
-18,980
| Closed | -$156K | – | 10070 |
|
|
2023
Q3 | $217K | Buy |
18,980
+2,615
| +16% | +$50.3K | ﹤0.01% | 4254 |
|
|
2023
Q2 | $414K | Buy |
16,365
+784
| +5% | +$24.4K | ﹤0.01% | 3509 |
|
|
2023
Q1 | $501K | Buy |
15,581
+2,260
| +17% | +$70.5K | ﹤0.01% | 3264 |
|
|
2022
Q4 | $245K | Sell |
13,321
-34,280
| -72% | -$784K | ﹤0.01% | 3980 |
|
|
2022
Q3 | $1.28M | Buy |
47,601
+31,375
| +193% | +$636K | ﹤0.01% | 2369 |
|
|
2022
Q2 | $224K | Sell |
16,226
-11,628
| -42% | -$179K | ﹤0.01% | 4470 |
|
|
2022
Q1 | $543K | Buy |
+27,854
| New | +$422K | ﹤0.01% | 3747 |
|
|
2021
Q2 | – | Sell |
-3,047
| Closed | -$87.9K | – | 10855 |
|
|
2021
Q1 | $85K | Sell |
3,047
-3,545
| -54% | -$98.1K | ﹤0.01% | 5964 |
|
|
2020
Q4 | $186K | Sell |
6,592
-1,098
| -14% | -$28.4K | ﹤0.01% | 4714 |
|
|
2020
Q3 | $193K | Buy |
+7,690
| New | +$202K | ﹤0.01% | 4162 |
|
|
2020
Q1 | – | Sell |
-8,814
| Closed | -$182K | – | 8429 |
|
|
2019
Q4 | $143K | Buy |
8,814
+5,302
| +151% | +$82.2K | ﹤0.01% | 4113 |
|
|
2019
Q3 | $45K | Sell |
3,512
-71
| -2% | -$869 | ﹤0.01% | 5125 |
|
|
2019
Q2 | $46K | Buy |
+3,583
| New | +$45.2K | ﹤0.01% | 4931 |
|
|
2018
Q4 | – | Sell |
-1,897
| Closed | -$41.8K | – | 7973 |
|
|
2018
Q3 | $47K | Sell |
1,897
-154
| -8% | -$4.19K | ﹤0.01% | 5233 |
|
|
2018
Q2 | $56K | Sell |
2,051
-276
| -12% | -$8.29K | ﹤0.01% | 4938 |
|
|
2018
Q1 | $71K | Buy |
+2,327
| New | +$74.9K | ﹤0.01% | 2087 |
|
|
2017
Q4 | – | Sell |
-4,559
| Closed | -$131K | – | 6847 |
|
|
2017
Q3 | $125K | Sell |
4,559
-1,127
| -20% | -$27.3K | 0.01% | 1529 |
|
|
2017
Q2 | $150K | Sell |
5,686
-1,865
| -25% | -$41.6K | 0.01% | 1422 |
|
|
2017
Q1 | $157K | Buy |
+7,551
| New | +$155K | 0.01% | 1402 |
|
|
2016
Q3 | – | Sell |
-694
| Closed | -$10.1K | – | 6586 |
|
|
2016
Q2 | $9K | Buy |
+694
| New | +$12.3K | ﹤0.01% | 3720 |
|
|
2016
Q1 | – | Sell |
-17,365
| Closed | -$593K | – | 6393 |
|
|
2015
Q4 | $593K | Buy |
17,365
+8,300
| +92% | +$288K | 0.05% | 366 |
|
|
2015
Q3 | $269K | Buy |
+9,065
| New | +$275K | 0.02% | 747 |
|
Other funds holding RVNC
Simplex Trading's RVNC Position: Q1 2025 in Review
Simplex Trading sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 38,598 shares — an estimated $117K sold.
Simplex Trading first reported a position in RVNC in Q3 2015 and held it in 25 quarters. The position peaked at $1.28M in Q3 2022. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.
- Simplex Trading reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
- Simplex Trading sold 38,598 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $117K.
- Simplex Trading first reported a position in Revance Therapeutics, Inc. in Q3 2015 and held it in 25 quarters.
- Simplex Trading's Revance Therapeutics, Inc. position peaked at $1.28M in Q3 2022.
- 1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.
Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.